Expanding access to nonprescription drugs and improving public health aren’t likely to result from a US Food and Drug Administration proposed rule targeting those and other goals, say Sidney Wolfe and other public health advocates.
The agency has comments from Wolfe and others submitted in November to consider among the 182 submitted to the docket –
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?